查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1559993

C 反应蛋白检测市场报告：2030 年趋势、预测与竞争分析

C Reactive Protein Testing Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

C反应蛋白检测趋势与预测

到 2030 年，全球 C 反应蛋白 (CRP) 检测市场预计将达到 47 亿美元，2024 年至 2030 年复合年增长率为 3.1%。该市场的主要驱动力是老年人口的增加、照护现场设备的日益采用以及医疗服务需求的增加。全球C反应蛋白检测市场的未来前景广阔，糖尿病、类风湿性关节炎、心血管疾病和发炎性肠道疾病市场蕴藏着机会。

  • Lucintel 预计免疫比浊法在预测期内仍将是最大的细分市场，因为它可以灵敏地测量各种 CRP 值。
  • 在这个市场中，由于心血管疾病的快速增加以及对心血管疾病诊断和监测的需求不断增长，心血管疾病仍将是最大的细分市场。
  • 由于该地区发炎疾病的盛行率不断上升、不健康的生活方式改变以及医疗保健支出较高，在预测期内，北美将继续成为最大的地区。

C反应蛋白检测市场的新兴趋势

C 反应蛋白 (CRP) 检测市场正在见证几个反映技术进步和医疗需求变化的关键趋势。这些趋势正在透过提高效率、准确性和可及性来塑造 CRP 测试的未来。

  • 高敏感性CRP检测：高敏感性CRP检测的广泛使用使得更准确地检测低水平发炎成为可能。这些测试为慢性病的早期诊断和监测提供了有价值的信息，透过更有针对性的干预措施改善患者的治疗结果。
  • 就地检验：照护现场CRP 检测设备的兴起使得在各种医疗环境中进行快速、轻鬆的检测成为可能。这些测试设备可提供即时结果，从而能够及时做出临床决策并改善初级和紧急医疗环境中的患者照护。
  • 数位健康整合：CRP 测试越来越多地与数位健康平台和电子健康记录整合。这种整合支援更好的资料管理、即时监控和改进的护理协调，从而提高 CRP 测试的整体有效性。
  • 自动化测试解决方案：CRP 测试实验室的自动化简化了工作流程并提高了测试吞吐量。自动化系统透过减少手动错误、提高一致性和效率，使 CRP 测试更加可靠和扩充性。
  • 具有成本效益的解决方案：人们越来越有兴趣开发具有成本效益的 CRP 测试解决方案，以提高可访问性，尤其是在资源匮乏的环境中。经济实惠的检测和简化的製造流程正在扩大 CRP 检测的范围并改善医疗保健公平性。

这些趋势透过提高测试灵敏度、便利性以及与数位健康工具的整合正在重塑 CRP 测试市场。对自动化和经济高效的解决方案的关注正在提高可及性和效率，推动患者照护和诊断准确性的进步。

C反应蛋白检测市场的最新趋势

C 反应蛋白 (CRP) 检测市场的最新趋势反映了技术的进步和对精确诊断工具日益增长的需求。这些发展正在提高各个地区 CRP 测试的能力和可近性。

  • 先进的检测技术：引进高灵敏度CRP检测和多重CRP检测，提升诊断准确性。这些技术还可以检测到较低的发炎，从而更详细地了解发炎状况。
  • 照护现场设备：新型照护现场CRP 测试设备正在变得流行，提供快速、方便的测试选项。这些设备在急诊医学和初级保健环境中特别有用，可快速提供结果以帮助立即进行临床决策。
  • 实验室自动化：实验室 CRP 测试过程的自动化正在提高效率和吞吐量。自动化系统减少了人工错误，简化了工作流程，并使 CRP 测试更加可靠且扩充性。
  • 数位健康整合：CRP 测试越来越多地与数位健康平台集成，以增强资料管理和即时监控。这种整合透过无缝资料共用支援更好的患者管理和协调护理。
  • 经济实惠的测试解决方案：经济高效的 CRP 测试解决方案的开发正在扩大访问范围，特别是在资源匮乏的环境中。负担得起的检测缩小了获得医疗保健的差距，并提高了服务不足地区的诊断能力。

这些发展透过提高准确性、效率和可近性来推动 CRP 测试市场的发展。检测技术、自动化和成本效益方面的创新正在改善患者照护并扩大 CRP 检测的全球范围。

C 反应蛋白检测市场的策略性成长机会

C 反应蛋白 (CRP) 测试市场在各种应用中呈现多种成长机会。这些机会是由技术进步和医疗保健需求增加所推动的。

  • 医院诊断：先进 CRP 检测技术在医院的扩展带来了巨大的成长机会。诊断能力的提高将推动对先进 CRP 检测解决方案的需求，以改善患者管理并支持更好的临床结果。
  • 初级保健：初级保健中的照护现场CRP 检测设备有成长机会。这些设备能够快速评估发炎，改善患者照护并促进门诊病人环境的及时干预。
  • 急诊医学：快速 CRP 检测在急诊医学的应用正在扩大。可携式、高效的 CRP 检测解决方案在紧急医疗环境中具有成长潜力，因为快速结果有助于急性疾病的诊断和管理。
  • 研究与开发：发炎疾病研究的进展为 CRP 检测创造了成长机会。先进的检测技术和创新的检测方法正在支持研究工作并推动临床实验室和实验室对 CRP 检测的需求。
  • 国际扩张：扩大新兴市场 CRP 测试的覆盖范围带来了成长机会。经济实惠且易于使用的检测解决方案可以弥补医疗保健取得方面的差距，并提高资源匮乏地区的诊断能力。

这些成长机会凸显了 CRP 测试在各种医疗保健环境中的广泛使用。技术进步和不断增长的全球需求正在推动市场发展，从而提高诊断能力并改善患者照护。

C反应蛋白检测市场的驱动因素与挑战

C反应蛋白（CRP）检测市场受到各种技术、经济和监管因素的影响。这些市场驱动因素和挑战影响诊断领域的市场成长、创新和可近性。

推动 C 反应蛋白检测市场的因素包括：

1.技术进步：CRP 检测技术的创新，例如高灵敏度检测和照护现场设备，透过提高诊断准确性和便利性来推动市场成长。这些进步满足了对更准确、更快速的发炎检测日益增长的需求。

2.医疗需求不断增加：由于全球医疗领域的扩张，对高可靠CRP检测的需求不断增加。医疗意识的提高和医疗基础设施的扩大正在推动对先进诊断工具的需求，以支持市场的扩张和发展。

3. 与数位健康整合：CRP 测试与数位健康平台整合可改善资料管理和患者照护。增强的连接性和即时监控能力将有助于更好的临床决策并推动市场成长。

4. 监管支援：支持性法律规范促进先进 CRP 测试技术的创新和采用。明确的指导方针和核准简化了市场准入并确保提供高品质的诊断解决方案。

5. 具有成本效益的解决方案：开拓负担得起的 CRP 测试选项可以增加市场的可及性，特别是在资源匮乏的环境中。具有成本效益的解决方案扩大了获得护理的机会，提高了诊断能力，并解决了获得护理方面的差异。

CRP 测试市场面临的挑战是：

1.先进技术高成本：先进CRP检测技术的成本高可能会限制准入并影响市场渗透率。昂贵的设备和检测可能会限制低收入地区和医疗机构的采用。

2. 复杂的法规环境：应对复杂的区域监管标准是一项挑战。製造商必须遵守各种法规，这增加了营运成本并使市场进入和扩张工作变得更加复杂。

3. 经济限制：经济波动会影响 CRP 测试技术的价格和可用性。卫生系统的预算限制可能会影响购买决策并减缓经济困难地区的市场成长。

技术进步、不断增长的医疗需求以及与数位健康的融合等市场驱动因素正在推动 CRP 检测市场向前发展。然而，需要解决高技术成本、复杂的法规环境和经济限制等挑战，以充分发挥市场潜力并确保广泛获得先进的诊断解决方案。

分段C反应蛋白测试

本研究包括按检测类型、应用和区域对全球 C 反应蛋白检测进行的预测。

C反应蛋白检测市场的国家展望

由于技术进步、快速诊断需求的增加以及各种区域趋势，C 反应蛋白 (CRP) 检测市场正在不断发展。这一趋势是由各种医疗系统对更准确、更有效的发炎标记测试的需求所推动的。

  • 美国：由于灵敏检测和就地检验设备的进步，美国市场的 CRP 检测正在强劲成长。这些创新使得能够更快、更准确地检测发炎，从而改善患者管理并支持个人化治疗策略。
  • 中国：由于医疗保健和诊断投资的增加，中国显着扩大了 CRP 检测基础设施。先进的 CRP 检测技术在医院和诊所的整合正在提高全国的诊断能力和患者照护。
  • 德国：在德国，我们致力于透过引入更复杂的分析平台来提高 CRP 测试的准确性。这些趋势是将先进诊断纳入常规医疗实践的更广泛趋势的一部分，旨在提高诊断准确性和患者治疗结果。
  • 印度：在印度，由于认知度和可及性的提高，CRP 检测市场正在快速成长。采用具有成本效益且易于使用的 CRP 检测解决方案正在扩大检测覆盖范围，特别是在农村和服务不足的地区，并改善整体医疗保健的可及性。
  • 日本：在日本，实验室晶片技术和自动化的创新正在 CRP 测试方面取得进展。这些进步简化了测试流程，缩短了周转时间，并提高了临床和研究环境中 CRP 测试的效率。

常问问题

Q1.市场规模为：

A1. 到 2030 年，全球 C 反应蛋白检测市场预计将达到 47 亿美元。

Q2.市场成长预测是多少：

A2. 2024年至2030年，全球C反应蛋白检测市场预计将以3.1%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素是：

A3. 该市场的主要驱动力是老年人口的增加、照护现场设备的采用增加以及医疗服务需求的增加。

Q4.市场的主要细分市场是：

A4.C反应蛋白检测市场前景广阔，在糖尿病、类风湿性关节炎、心血管疾病和发炎性肠道疾病市场中蕴藏着机会。

Q5.市场的主要企业是：

A5.C 反应蛋白检测的主要企业有：

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck KGaAA
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计免疫比浊法在预测期内仍将是最大的细分市场，因为它可以灵敏地测量各种 CRP 水平。

Q7.未来五年预计哪个地区的市场成长最大？

A7. 由于该地区发炎疾病的流行、不健康的生活方式的改变和高额的医疗保健支出，在预测期内，北美将继续成为最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章 全球C反应蛋白检测市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球C反应蛋白检测市场趋势（2018-2023）与预测（2024-2030）
  • 按检测类型分類的全球 C 反应蛋白检测市场
    • 酵素免疫分析法
    • 化学冷光免疫检测
    • 免疫比浊法
    • 其他的
  • 按应用分類的全球 C 反应蛋白检测市场
    • 糖尿病
    • 类风湿性关节炎
    • 心血管疾病
    • 发炎性肠道疾病
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球C反应蛋白检测市场（按地区）
  • 北美C反应蛋白检测市场
  • 欧洲C反应蛋白检测市场
  • 亚太C反应蛋白检测市场
  • 其他地区C反应蛋白检测市场

第五章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按检测类型分類的全球 C 反应蛋白检测市场成长机会
    • 全球 C 反应蛋白测试市场成长机会（按应用）
    • 全球 C 反应蛋白测试市场成长机会（按地区）
  • 全球C反应蛋白检测市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球 C 反应蛋白检测市场的产能扩张
    • 全球C反应蛋白检测市场的合併、收购与合资
    • 认证和许可

第七章主要企业概况

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck KGaAA
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech
简介目录

C Reactive Protein Testing Trends and Forecast

The future of the global C reactive protein testing market looks promising with opportunities in the diabetes, rheumatoid arthritis, cardiovascular disease, and inflammatory bowel disease markets. The global C reactive protein testing market is expected to reach an estimated $4.7 billion by 2030 with a CAGR of 3.1% from 2024 to 2030. The major drivers for this market are increasing geriatric population, growing adoption of point-of-care devices, and rising demand for healthcare services.

  • Lucintel forecasts that immunoturbidimetric assay will remain the largest segment over the forecast period as it provides high sensitivity for measuring a wide range of CRP levels.
  • Within this market, cardiovascular disease will remain the largest segment due to surge in cardiovascular diseases and growing need to diagnose and monitor cardiovascular diseases.
  • North America will remain the largest region over the forecast period due to growing prevalence of inflammatory diseases, change in unhealthy lifestyle, and high healthcare expenditure in the region.

Emerging Trends in the C Reactive Protein Testing Market

The C-Reactive Protein (CRP) testing market is experiencing several key trends that reflect advancements in technology and shifts in healthcare needs. These trends are shaping the future of CRP testing by enhancing efficiency, accuracy, and accessibility.

  • High-Sensitivity CRP Tests: Increasing use of high-sensitivity CRP tests enables more precise detection of low levels of inflammation. These tests provide valuable information for early diagnosis and monitoring of chronic conditions, improving patient outcomes through more targeted interventions.
  • Point-of-Care Testing: The rise of point-of-care CRP testing devices allows for rapid and convenient testing in various healthcare settings. These devices facilitate immediate results, enabling timely clinical decisions and enhancing patient care in both primary and emergency settings.
  • Integration with Digital Health: CRP testing is increasingly integrated with digital health platforms and electronic health records. This integration supports better data management, real-time monitoring, and improved coordination of care, enhancing the overall effectiveness of CRP testing.
  • Automated Testing Solutions: Automation in CRP testing laboratories is streamlining workflows and increasing testing throughput. Automated systems reduce manual errors, improve consistency, and enhance efficiency, making CRP testing more reliable and scalable.
  • Cost-Effective Solutions: There is a growing focus on developing cost-effective CRP testing solutions to increase accessibility, particularly in low-resource settings. Affordable tests and streamlined production processes are expanding the reach of CRP testing and improving healthcare equity.

These trends are reshaping the CRP testing market by enhancing test sensitivity, convenience, and integration with digital health tools. The emphasis on automation and cost-effective solutions is improving accessibility and efficiency, driving advancements in patient care and diagnostic accuracy.

Recent Developments in the C Reactive Protein Testing Market

Recent developments in the C-Reactive Protein (CRP) testing market reflect advancements in technology and increasing demand for precise diagnostic tools. These developments are enhancing the capabilities and accessibility of CRP testing across various regions.

  • Advanced Testing Technologies: The introduction of high-sensitivity and multiplex CRP assays is improving diagnostic accuracy. These technologies allow for the detection of lower levels of inflammation and provide more detailed insights into inflammatory conditions.
  • Point-of-Care Devices: New point-of-care CRP testing devices are becoming more prevalent, offering rapid and convenient testing options. These devices are particularly beneficial in emergency and primary care settings, providing quick results that aid in immediate clinical decisions.
  • Automation in Labs: The automation of CRP testing processes in laboratories is increasing efficiency and throughput. Automated systems reduce manual errors and streamline workflows, making CRP testing more reliable and scalable.
  • Integration with Digital Health: CRP testing is increasingly integrated with digital health platforms, enhancing data management and real-time monitoring. This integration supports better patient management and more coordinated care through seamless data sharing.
  • Affordable Testing Solutions: The development of cost-effective CRP testing solutions is expanding access, especially in low-resource settings. Affordable tests help bridge the gap in healthcare access, improving diagnostic capabilities in underserved areas.

These developments are advancing the CRP testing market by improving accuracy, efficiency, and accessibility. Innovations in testing technologies, automation, and cost-effectiveness are enhancing patient care and expanding the reach of CRP testing globally.

Strategic Growth Opportunities for C Reactive Protein Testing Market

The C-Reactive Protein (CRP) testing market presents several growth opportunities across various applications. These opportunities are driven by advancements in technology and increasing healthcare demands.

  • Hospital Diagnostics: The expansion of advanced CRP testing technologies in hospitals presents significant growth opportunities. Enhanced diagnostic capabilities improve patient management and support better clinical outcomes, driving demand for sophisticated CRP testing solutions.
  • Primary Care Settings: Point-of-care CRP testing devices in primary care settings offer opportunities for growth. These devices enable rapid inflammation assessment, improving patient care and facilitating timely interventions in outpatient environments.
  • Emergency Medicine: The use of rapid CRP testing in emergency medicine is expanding. Quick results help in diagnosing and managing acute conditions, presenting growth potential for portable and efficient CRP testing solutions in emergency settings.
  • Research and Development: Increasing research into inflammatory diseases creates growth opportunities for CRP testing. Advanced testing technologies and innovative assays support research efforts, driving demand for CRP tests in clinical and research laboratories.
  • Global Expansion: Expanding access to CRP testing in emerging markets offers growth opportunities. Affordable and accessible testing solutions can bridge gaps in healthcare access, improving diagnostic capabilities in low-resource regions.

These growth opportunities highlight the expanding applications of CRP testing across various healthcare settings. Advancements in technology and increasing global demand are driving the market, enhancing diagnostic capabilities and improving patient care.

C Reactive Protein Testing Market Driver and Challenges

The C-Reactive Protein (CRP) testing market is influenced by various technological, economic, and regulatory factors. These drivers and challenges impact market growth, innovation, and accessibility in the diagnostic sector.

The factors responsible for driving the c reactive protein testing market include:

1. Technological Advancements: Innovations in CRP testing technologies, such as high-sensitivity assays and point-of-care devices, drive market growth by enhancing diagnostic accuracy and convenience. These advancements meet the increasing demand for more precise and rapid inflammation detection.

2. Increasing Healthcare Demand: The growing global healthcare sector increases the need for reliable CRP testing. Rising awareness and expanding healthcare infrastructure drive demand for advanced diagnostic tools, supporting market expansion and development.

3. Integration with Digital Health: The integration of CRP testing with digital health platforms improves data management and patient care. Enhanced connectivity and real-time monitoring capabilities drive market growth by facilitating better clinical decision-making.

4. Regulatory Support: Supportive regulatory frameworks promote innovation and adoption of advanced CRP testing technologies. Clear guidelines and approvals streamline market entry and ensure the availability of high-quality diagnostic solutions.

5. Cost-Effective Solutions: The development of affordable CRP testing options enhances market accessibility, particularly in low-resource settings. Cost-effective solutions expand reach and improve diagnostic capabilities, addressing disparities in healthcare access.

Challenges in the c reactive protein testing market are:

1. High Cost of Advanced Technologies: The high cost of advanced CRP testing technologies can limit accessibility and impact market penetration. Expensive equipment and assays may restrict adoption in lower-income regions and healthcare settings.

2. Complex Regulatory Environment: Navigating complex and varying regulatory standards across regions poses challenges. Manufacturers must comply with diverse regulations, increasing operational costs and complicating market entry and expansion efforts.

3. Economic Constraints: Economic fluctuations can affect the affordability and availability of CRP testing technologies. Budget constraints in healthcare systems may impact purchasing decisions and slow market growth in economically challenged regions.

The drivers of technological advancements, increasing healthcare demand, and integration with digital health are propelling the CRP testing market forward. However, challenges such as high technology costs, complex regulatory environments, and economic constraints must be addressed to fully realize market potential and ensure widespread access to advanced diagnostic solutions.

List of C Reactive Protein Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies C reactive protein testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the C reactive protein testing companies profiled in this report include-

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck KGaAA
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech

C Reactive Protein Testing by Segment

The study includes a forecast for the global C reactive protein testing by assay type, application, and region.

C Reactive Protein Testing Market by Assay Type [Analysis by Value from 2018 to 2030]:

  • Enzyme-Linked Immunosorbent Assay
  • Chemiluminescence Immunoassay
  • Immunoturbidimetric Assay
  • Others

C Reactive Protein Testing Market by Application [Analysis by Value from 2018 to 2030]:

  • Diabetes
  • Rheumatoid Arthritis
  • Cardiovascular Disease
  • Inflammatory Bowel Disease
  • Others

C Reactive Protein Testing Market by Region [Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the C Reactive Protein Testing Market

The C-Reactive Protein (CRP) testing market is evolving with advancements in technology, increasing demand for rapid diagnostics, and varying regional trends. These developments are driven by the need for more accurate and efficient inflammatory marker testing across different healthcare systems.

  • United States: The U.S. market has seen significant growth in CRP testing due to advancements in high-sensitivity assays and point-of-care testing devices. These innovations enable faster and more accurate detection of inflammation, supporting improved patient management and personalized treatment strategies.
  • China: In China, there has been a notable expansion in CRP testing infrastructure, driven by increased investments in healthcare and diagnostics. The integration of advanced CRP testing technologies in hospitals and clinics is improving diagnostic capabilities and patient care across the country.
  • Germany: Germany is focusing on enhancing the precision of CRP tests with the introduction of more sophisticated analytical platforms. These developments are part of a broader trend towards integrating advanced diagnostics into routine healthcare practices, aiming to improve diagnostic accuracy and patient outcomes.
  • India: In India, the CRP testing market is growing rapidly due to increased awareness and accessibility. The adoption of cost-effective and user-friendly CRP testing solutions is expanding the reach of these tests, particularly in rural and underserved areas, improving overall healthcare access.
  • Japan: Japan is advancing CRP testing with innovations in lab-on-a-chip technologies and automation. These advancements are streamlining testing processes, reducing turnaround times, and enhancing the efficiency of CRP tests in both clinical and research settings.

Features of the Global C Reactive Protein Testing Market

Market Size Estimates: C reactive protein testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: C reactive protein testing market size by assay type, application, and region in terms of value ($B).

Regional Analysis: C reactive protein testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different assay types, applications, and regions for the C reactive protein testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the C reactive protein testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the C reactive protein testing market size?

Answer: The global C reactive protein testing market is expected to reach an estimated $4.7 billion by 2030.

Q2. What is the growth forecast for C reactive protein testing market?

Answer: The global C reactive protein testing market is expected to grow with a CAGR of 3.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the C reactive protein testing market?

Answer: The major drivers for this market are increasing geriatric population, growing adoption of point-of-care devices, and rising demand for healthcare services.

Q4. What are the major segments for C reactive protein testing market?

Answer: The future of the C reactive protein testing market looks promising with opportunities in the diabetes, rheumatoid arthritis, cardiovascular disease, and inflammatory bowel disease markets.

Q5. Who are the key C reactive protein testing market companies?

Answer: Some of the key C reactive protein testing companies are as follows:

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck KGaAA
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech

Q6. Which C reactive protein testing market segment will be the largest in future?

Answer: Lucintel forecasts that immunoturbidimetric assay will remain the largest segment over the forecast period as it provides high sensitivity for measuring a wide range of CRP levels.

Q7. In C reactive protein testing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing prevalence of inflammatory diseases, change in unhealthy lifestyle, and high healthcare expenditure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the C reactive protein testing market by assay type (enzyme-linked immunosorbent assay, chemiluminescence immunoassay, immunoturbidimetric assay, and others), application (diabetes, rheumatoid arthritis, cardiovascular disease, inflammatory bowel disease, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
  • Market Report

Table of Contents

1. Executive Summary

2. Global C Reactive Protein Testing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global C Reactive Protein Testing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global C Reactive Protein Testing Market by Assay Type
    • 3.3.1: Enzyme-Linked Immunosorbent Assay
    • 3.3.2: Chemiluminescence Immunoassay
    • 3.3.3: Immunoturbidimetric Assay
    • 3.3.4: Others
  • 3.4: Global C Reactive Protein Testing Market by Application
    • 3.4.1: Diabetes
    • 3.4.2: Rheumatoid Arthritis
    • 3.4.3: Cardiovascular Disease
    • 3.4.4: Inflammatory Bowel Disease
    • 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global C Reactive Protein Testing Market by Region
  • 4.2: North American C Reactive Protein Testing Market
    • 4.2.1: North American C Reactive Protein Testing Market by Assay Type: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Immunoturbidimetric Assay, and Others
    • 4.2.2: North American C Reactive Protein Testing Market by Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, and Others
  • 4.3: European C Reactive Protein Testing Market
    • 4.3.1: European C Reactive Protein Testing Market by Assay Type: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Immunoturbidimetric Assay, and Others
    • 4.3.2: European C Reactive Protein Testing Market by Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, and Others
  • 4.4: APAC C Reactive Protein Testing Market
    • 4.4.1: APAC C Reactive Protein Testing Market by Assay Type: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Immunoturbidimetric Assay, and Others
    • 4.4.2: APAC C Reactive Protein Testing Market by Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, and Others
  • 4.5: ROW C Reactive Protein Testing Market
    • 4.5.1: ROW C Reactive Protein Testing Market by Assay Type: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Immunoturbidimetric Assay, and Others
    • 4.5.2: ROW C Reactive Protein Testing Market by Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global C Reactive Protein Testing Market by Assay Type
    • 6.1.2: Growth Opportunities for the Global C Reactive Protein Testing Market by Application
    • 6.1.3: Growth Opportunities for the Global C Reactive Protein Testing Market by Region
  • 6.2: Emerging Trends in the Global C Reactive Protein Testing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global C Reactive Protein Testing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global C Reactive Protein Testing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: F. Hoffmann-La Roche
  • 7.3: Danaher
  • 7.4: Quest Diagnostics
  • 7.5: Siemens Healthineers
  • 7.6: Abbott
  • 7.7: Merck KGaAA
  • 7.8: Zoetis
  • 7.9: Ortho Clinical Diagnostics
  • 7.10: Getein Biotech